Details for Patent: 10,231,931

Which drugs does patent 10,231,931 protect, and when does it expire?

Patent 10,231,931 protects LEVOLET and is included in one NDA.

Summary for Patent: 10,231,931

Title:	Thyroid hormone oral dosage forms and methods of using the same
Abstract:	Novel thyroid hormone oral dosage forms and methods of making and using the thyroid hormone oral dosage forms are disclosed.
Inventor(s):	Phadke; Shivaji (Berkeley Heights, NJ), Parikh; Vaishnavi (Sellersville, PA)
Assignee:	GENUS LIFESCIENCES INC. (Allentown, PA)
Application Number:	15/934,185
Patent Claim Types: see list of patent claims	Compound; Dosage form;

Drugs Protected by US Patent 10,231,931

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-003	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No			Y
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-004	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No			Y
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-005	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No			Y
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-006	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No			Y
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-007	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No			Y